Not logged in, please login to view portfolio!

ABOT Share Price | Abbott Laboratories (Pakistan) Limited

ABOT Share Price History

ABOT (Abbott Laboratories (Pakistan) Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. ABOT share price / stock price today is 654.76 PKR. Today volume traded in ABOT is 450, price change is -1.44%, high price is 662.00 PKR, and low price is 650.03 PKR.

Company Snapshot

loading
ABOT
2022-06-29 16:02:00
Current
654.76
Change
-9.59
Change %
-1.44%
Volume
450
Price to Earnings Ratio
10.74
Earning per Share
60.95
Book Value
172.39
Price to Book
4.05
Market Cap
64.1 B
Dividend
40.00
Dividend Yield (%)
5.73 %
Debt to Equity
0.00
Net Profit Margin
13.42 %
Gross Profit Margin
36.82 %
Current Ratio
1.73
Face Value
10.00
Shares
97.9 M
FreeFloat
21.07 M
Free Float %
21.53
Equity to Asset(%)
56.03
Interest
109.14
Beta
0.58
Upper Cap
714.18
Lower Cap
614.52
52 Week High
819.00
52 Week Low
613.50
High
662.00
Low
650.03
Previous
664.35
loading

Company Brands

image
image
ABOT Performance
Return (%) Absolute Return
1 Week 1 Month 3 Month 6 Month 1 Year
Return -1.068% 2.616% -6.328% -10.953% -15.235%

Company Financials
Company Announcements
Date Announce Title Attachments
2022-05-24 Resignation of Company Secretary View PDF
2022-05-09 Credit of Final Cash Dividend View PDF
2022-05-06 Change of Chairman View PDF
2022-05-06 Transmission of Quarterly Report for the Period Ended March 31, 2022 View PDF
2022-04-28 Financial Results for the Quarter ended March 31, 2022 View PDF
2022-03-29 Transmission of Annual Report for the Year Ended December 31, 2021 View PDF
2022-03-29 Notice of Annual General Meeting View PDF
2022-02-24 Financial Results for the Year Ended December 31, 2021 View PDF
2022-02-17 Board Meeting View PDF
2021-12-10 Notice for Corporate Briefing Session View PDF
2021-10-29 Transmission of Quarterly Report for the Period Ended September 30, 2021 View PDF
2021-10-27 Financial Results for the Quarter Ended September 30, 2021 View PDF
2021-10-21 Board Meeting View PDF
2021-09-23 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2021-09-22 Dispatch of Interim Cash Dividend View PDF
2021-08-27 Transmission of Quarterly Report for the Period Ended June 30, 2021 View PDF
2021-08-27 Financial Results for the Quarter Ended June 30, 2021 View PDF
2021-08-17 Board Meeting View PDF
2021-06-04 Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations View
2021-05-04 Credit of Final Cash Dividend REVOKED View
2021-05-04 Credit of Final Cash Dividend View
2021-05-04 Credit of Final Cash Dividend View
2021-04-30 Transmission of Quarterly Report for the Period Ended March 31, 2021 View PDF
2021-04-23 Financial Results for the 1st Quarter Ended March 31, 2021 View PDF
2021-04-22 Certified Copy of Resolution passed at the 72nd Annual General Meeting View PDF
2021-04-16 Board Meeting View
2021-04-06 Board Meeting Other Than Financial Results View PDF
2021-03-31 Transmission of Annual Report for the Year Ended December 31st, 2020 View PDF
2021-03-29 Notice of Annual General Meeting View PDF
2021-03-08 ABOT | Abbott Laboratories (Pakistan) Limited PDF
2021-03-08 Unusual Movement in price or volume of M/s Abbott Laboratories (Pakistan) Limited (ABOT) View
2021-02-26 Financial Results for the Year Ended December 31,2020 View PDF
2021-02-15 Board Meeting PDF

About Company

Abbott Laboratories (Pakistan) Limited (the Company) is a public limited company incorporated in Pakistan on July 02, 1948. The Company is principally engaged in the manufacture, import and marketing of research based pharmaceutical, nutritional, diagnostic, diabetes care, molecular devices, hospital and consumer products.

Address
Plot No. 258 & 324, Opposite Rad
Website
www.pk.abbott
Key People
Mr. Munir A. Shaikh Chairperson
Mr. Syed Anis Ahmed CEO
Mr. Humayun Altaf Company Secretary

Page description

ABOT (Abbott Laboratories (Pakistan) Limited) listed in PSX,KSE100,ALLSHR,KMI30,KMIALLSHR. ABOT Share Price / Stock Price is 654.76 PKR. You can also check; Share Price History, ABOTPayouts, Annoucements, Snapshot, Company details, Fundamentals, Technicals and much more.

ABOT Share Price ABOT Stock Price Abbott Laboratories (Pakistan) Limited psx stock kse100 stock ABOT Stock Price KSE100 ALLSHR KMI30 KMIALLSHR Share price History ABOT Payouts Annoucements Snapshot ABOT Address ABOT CEO Book Value Price/Book Ratio Dividend Yield Earning Per Share Net Profit Margin Gross Profit Margin Price to Sales Ratio Long Term Debt to Equity Interest Cover (Times) Equity to Assets (%) Current Ratio (Times) Cash Payout Ratio Technical Indicators Moving Averages ABOT Chairperson ABOT Secretary ABOT Website About ABOT

Company Health

Company Health

My Watchlist

Not logged in, please login to view watchlist!

Today's Market Performers KSE100

Change
loading

If you are someone who is keen on investments but does not have the time to research, identify stock market patterns, and keep track of stocks, forex, mutual funds, cryptocurrencies and other commodities like Gold and silver, then Sarmaaya is your meeting place, the crossroads where you can find everything you need to make the best decisions in the trading market. Based on unbiased, accurate and free information.

© 2022 SARMAAYA.PK

abcData (Pvt) Limited (Sarmaaya) is a Pakistan Stock Exchange (PSX) authorized data redistributor. Sarmaaya & CS Solutions (Pvt.) Limited (CS) do not guarantee the timeliness, accurateness, or completeness of any data or information on the website. Sarmaaya & CS makes no warranties, express or implied, as to Sarmaaya & CS or any data or values relating thereto or results to be obtained therefrom, and expressly disclaims all warranties of merchantability and fitness for a particular purpose with respect thereto. To the maximum extent allowed by law, Sarmaaya & CS, its licensors, and their respective employees, contractors, agents, suppliers and vendors shall have no liability or responsibility whatsoever for any injury or damages – whether direct, indirect, consequential, incidental, punitive or otherwise – arising in connection with Sarmaaya & CS or any data or values relating thereto – whether arising from their negligence or otherwise. Nothing in the website shall constitute or be construed as an offering of financial instruments or as investment advice or investment recommendations (i.e., recommendations as to whether or not to “buy”, “sell”, “hold”, or to enter or not to enter into any other transaction involving any specific interest or interests) by Sarmaaya & CS or a recommendation as to an investment or other strategy by Sarmaaya & CS. Data and other information available via the website should not be considered as information sufficient upon which to base an investment decision.